Ramy Tadros - MetLife Pres Bus
| MWZ Stock | EUR 81.50 0.93 1.13% |
Insider
Ramy Tadros is Pres Bus of MetLife
| Age | 47 |
| Phone | 212 578 9500 |
| Web | https://www.metlife.com |
Ramy Tadros Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ramy Tadros against MetLife stock is an integral part of due diligence when investing in MetLife. Ramy Tadros insider activity provides valuable insight into whether MetLife is net buyers or sellers over its current business cycle. Note, MetLife insiders must abide by specific rules, including filing SEC forms every time they buy or sell MetLife'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ramy Tadros over a month ago Acquisition by Ramy Tadros of 28113 shares of MetLife at 69.16 subject to Rule 16b-3 | ||
Ramy Tadros over six months ago Disposition of 4026 shares by Ramy Tadros of MetLife at 71.9025 subject to Rule 16b-3 |
MetLife Management Efficiency
MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Nobuya Kato | Japan Tobacco | N/A | |
| Muneaki Fujimoto | Japan Tobacco | N/A | |
| Simon Augustesen | Scandinavian Tobacco Group | N/A | |
| Naohiro Minami | Japan Tobacco | 59 | |
| Lawrence Schubert | Westlake Chemical | N/A | |
| Masaki Miyajima | Shin Etsu Chemical Co | N/A | |
| Shunzo Mori | Shin Etsu Chemical Co | N/A | |
| Robert Buesinger | Westlake Chemical | 66 | |
| Yukihito Adachi | Shin Etsu Chemical Co | N/A | |
| Mette Valentin | Scandinavian Tobacco Group | N/A | |
| Yukihiro Matsui | Shin Etsu Chemical Co | N/A | |
| Mark CPA | Westlake Chemical | 66 | |
| Lars Wassberg | Scandinavian Tobacco Group | N/A | |
| Susumu Ueno | Shin Etsu Chemical Co | 80 | |
| Dinesh Thotakura | Japan Tobacco | N/A | |
| Dorte Morell | Scandinavian Tobacco Group | N/A | |
| Masahiko Todoroki | Shin Etsu Chemical Co | N/A | |
| Mutsuo Iwai | Japan Tobacco | 63 | |
| Osamu Hirose | Japan Tobacco | N/A | |
| Thomas Janssens | Westlake Chemical | N/A | |
| KarlMartin Schellerer | Westlake Chemical | N/A | |
Management Performance
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 |
MetLife Leadership Team
Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michel Khalaf, Pres CEO | ||
| John Hall, VP Relations | ||
| Bill Pappas, Ex Operations | ||
| Randolph Clerihue, Chief Officer | ||
| Steven Goulart, Ex Officer | ||
| Pawan Verma, Ex Officer | ||
| Stephen Gauster, Exec Counsel | ||
| John CPA, Ex CFO | ||
| Ramy Tadros, Pres Bus |
MetLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 73.72 B | |||
| Shares Outstanding | 779.1 M | |||
| Shares Owned By Insiders | 16.00 % | |||
| Shares Owned By Institutions | 75.79 % | |||
| Price To Earning | 6.57 X | |||
| Price To Book | 2.24 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in MetLife Stock
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in MetLife Stock please use our How to Invest in MetLife guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.